Decera Clinical Education Medical Specialties Podcast

The key to effective IgG4-related disease (IgG4-RD) management is early recognition, accurate diagnosis, and timely treatment to prevent irreversible organ damage. Listen in to learn from expert faculty about recognizing common disease manifestations, distinguishing IgG4-RD from key mimicking conditions, assessing multiorgan involvement, and applying evidence-based treatment strategies to reduce relapse risk and improve patient outcomes.

Presenters

Yasmin G. Hernandez-Barco, MD
MGB Director of the Center for Pancreatic Disease
AMC Division of Gastroenterology, Hepatology, and Endoscopy
Outpatient Director, Complicated Pancreatitis Treatment Center
Assistant Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Guy Katz, MD, MS
Associate Physician, Division of Rheumatology, Inflammation, Immunity
Mass General Brigham
Instructor, Harvard Medical School
Boston, Massachusetts

Arezou Khosroshahi, MD
Professor of Medicine
Director of Clinical Trials
Rheumatology Division
Emory University School of Medicine
Atlanta, Georgia

Jai Radhakrishnan, MD, MS
Professor of Medicine
Clinical Director, Nephrology
Columbia University Vagelos College of Physicians and Surgeons
New York, New York

Chuck Vega, MD, FAAFP
Health Sciences Clinical Professor
UC Irvine Department of Family Medicine
Director, UCI Program in Medical Education for the Latino Community
Assistant Dean for Culture and Community Education
UC Irvine School of Medicine
Irvine, California

Link to full program:
https://bit.ly/4k6oQOe

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, 2 experts discuss the evolving role of weekly insulin therapy in modern type 2 diabetes (T2D) management. They share practical considerations for initiating or switching to these novel agents, including how to accurately convert daily doses, follow titration schedules, and support adherence and patient preferences through shared decision-making. Learn how you can ensure optimized glycemic control and reduced treatment burden in your patients with T2D by integrating weekly insulin therapies in your endocrinology, diabetology, or primary care practice.

Presenters

Richard E. Pratley, MD
Samuel E. Crockett Chair in Diabetes Research
Medical Director, AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead
AdventHealth Translational Research Institute
Adjunct Professor of Medicine
Johns Hopkins University School of Medicine
Orlando, Florida

Jay H. Shubrook, DO, FAAFP, FACOFP
Professor, Diabetologist
Department of Clinical Sciences and Community Medicine
Touro University California, College of Osteopathic Medicine
Vallejo, California

Link to full program:
https://bit.ly/4wyjOg7

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Two experts in obesity medicine discuss the latest advances in obesity care, including:

• Current data for incretin-based therapies
• Beyond the scale—individualizing OMM selection based on weight-related comorbidities and cardiometabolic risk
• Common contraindications and warnings associated with certain OMMs
• Shared decision-making strategies to inform treatment selection.

Presenters
Amy Butts, PA-C, DFAAPA, BC-ADM, CDCES
Endocrine Physician Associate
WVU Medicine Wheeling Hospital
Immediate Past President of American Society of Endocrine Physician Associates
Wellsburg, West Virginia

Nicholas Pennings, DO
Professor of Family Medicine
Campbell University School of Osteopathic Medicine
Director of Clinical Education
Obesity Medicine Association
Buies Creek, North Carolina

Link to full program:
https://bit.ly/4v7eIY4

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Four inflammatory bowel disease (IBD) experts explore case-based strategies for optimizing advanced IBD therapy and long-term disease management early in real-world practice. They discuss practical approaches for implementing treat-to-target via strategic treatment sequencing, therapeutic drug monitoring, and maintenance approaches while supporting individualized, evidence-based care for patients with IBD.

Presenters

Jessica R. Allegretti, MD, MPH, FACG, AGAF
Medical Director, Infusion Services
Director, Crohn’s and Colitis Center
Director of Clinical Research
Director, Fecal Microbiota Transplant Program
Division of Gastroenterology, Hepatology and Endoscopy
Brigham and Women’s Hospital
Associate Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Jordan E. Axelrad, MD, MPH, AGAF, FACG, FCCF
Co-Director, Inflammatory Bowel Disease Center at NYU Langone Health
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
NYU Grossman School of Medicine
New York, New York

Russell D. Cohen, MD, FACG, AGAF
Professor of Medicine, Pritzker School of Medicine
Co-Director, Digestive Diseases Center
Clinical Director, Inflammatory Bowel Disease Center
Co-Director, Advanced IBD Fellowship Program
The University of Chicago Medicine
Chicago, Illinois

Amy Stewart, MSN, FNP-C
Lead Advanced Practice Provider
Capital Digestive Care
Washington, DC

Link to full program:
https://bit.ly/4wvm7l4

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

As current understandings of obesity (ie, a chronic disease requiring long-term management) are adopted across the world, screening and treatment can no longer follow a one-size-fits-all approach. Listen in as 3 global experts in obesity medicine highlight the emerging evidence from recent conferences that are changing real-world practice today. Learn how the latest findings apply to specific patient populations across the United States, Europe, and Asia as well as why healthcare professionals should individualize treatment based on patient preferences and relevant risk factors.

Presenters:

Stephano Del Prato, MD
Professor Emeritus of Endocrinology
University of Pisa
Pisa, Italy

Soo Lim, MD, PhD
Professor of Medicine
Department of Internal Medicine
Seoul National University College of Medicine and Seoul National University Bundang Hospital
Seoul, South Korea

Donna H. Ryan, MD
Professor Emerita
Pennington Biomedical Research Center
Louisiana State University
New Orleans, Louisiana

Link to full program:
https://bit.ly/4pwFhEo

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this podcast, Jennifer Green, MD, and Jay H. Shubrook, DO, FAAFP, FACOFP, share strategies for integrating incretin-based therapies in type 2 diabetes (T2D) management in the primary care setting, including:

• Importance of moving beyond a glucose-centric approach to T2D care
• Current evidence for incretin-based therapies in T2D
• Rationale for integrating these therapies into the primary care setting
• Shared decision-making strategies to discuss optimal T2D treatment options with patients
• Timing for endocrinology referral

Presenters:

Jennifer Green, MD
Professor of Medicine
Division of Endocrinology
Duke Clinical Research Institute
Duke University School of Medicine
Durham, North Carolina

Jay H. Shubrook, DO, FAAFP, FACOFP
Professor, Diabetologist
Department of Clinical Sciences and Community Medicine
Touro University California, College of Osteopathic Medicine
Vallejo, California

Full program link:
https://bit.ly/4uSKCqv

Get access to all of our new podcasts by subscribing to the Decera Clinical Education Multispecialty Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Nancy Reau, MD, reviews key highlights of the most impactful primary biliary cholangitis (PBC) research and gain insights on how to apply these new advances to clinical practice.

Topics covered include:

• Treatment Goals
• Long-term Data With PPAR Agonists
• Investigational Therapies for Pruritus

Presenter:

Nancy Reau, MD
Professor of Medicine
Richard B. Capps Chair of Hepatology
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Rush University Medical Center
Chicago, Illinois

To download the accompanying slides, visit the program page for this episode:
https://bit.ly/4b2d6YD

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Jay H. Shubrook, DO, FACOFP, FAAFP, and Chrisopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA, discuss the latest advances in caring for patients with overweight or obesity in the primary care setting, including:

• The Lancet Commission’s new obesity definitions and diagnostic criteria
• Key data on incretin-based antiobesity medications like semaglutide and tirzepatide
• Best practices for patient discussions
• Strategies for incorporating new evidence in your primary care practice

Presenters
Jay H. Shubrook, DO, FACOFP, FAAFP
Professor and Diabetologist
Department of Clinical Sciences and Community Health
Touro University California College of Osteopathic Medicine
Vallejo, California

Christopher Weber, MD, FAAP, FACP, CSCS, daBOM, FOMA
Bariatric Services Medical Director, Ascension Wisconsin
Obesity Medicine Director, Ascension Columbia St Mary’s Bariatric Center
Trustee, Obesity Medicine Association
Adjunct Assistant Professor of Pediatrics
Medical College of Wisconsin
Milwaukee, Wisconsin

Link to full program:
https://bit.ly/4rG7QQp

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Historically, key symptoms of primary biliary cholangitis (PBC), such as pruritus and fatigue, have been understudied and undertreated. Listen now to learn how symptom management should be considered independently of PBC management, and how new therapeutic agents can help.

Topics covered include:

• Mechanisms of pruritus and fatigue in PBC
• Nonpharmacologic treatment options
• An overview of clinical trial data supporting second-line agents for symptom management:
• Bezafibrate
• Elafibranor
• Seladelpar
• Investigational agents:
• Volixibat
• Linerixibat
• Setanaxib

This episode is the third of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode:
https://bit.ly/44ZJ5os

Presenters:
Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Aliya F. Gulamhusein, MD,
MPH, FRCPC
Professorship in PSC Research
Clinician Investigator, Toronto General Hospital
Assistant Professor, University of Toronto
Division of Gastroenterology and Hepatology
University Health Network
Toronto, Canada

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

New therapeutic agents for second-line treatment are raising the bar for primary biliary cholangitis (PBC) management. Listen now to learn how to incorporate these new agents into clinical practice and how these agents will impact attainment of treatment goals.

Topics covered include:

• Available agents for second-line treatment of PBC
• An overview of clinical trial data supporting second-line agents:
• Obeticholic acid (OCA)
• Bezafibrate
• Elafibranor
• Seladelpar

This episode is the second of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/48MEc3r

Presenters:

Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Aliya F. Gulamhusein, MD, MPH, FRCPC
Professorship in PSC Research
Clinician Investigator, Toronto General Hospital
Assistant Professor, University of Toronto
Division of Gastroenterology and Hepatology
University Health Network
Toronto, Canada

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Advancements in our understanding of primary biliary cholangitis (PBC) and new therapeutic agents have reshaped the care landscape of PBC. Listen now to learn how these developments are helping to redefine and elevate treatment goals. Topics covered include:

• How and when to assess treatment response
• Risk factors in PBC
• Biochemical treatment response and fibrosis stage as predictors of transplant-free survival
• Dynamics of liver stiffness measurements and clinical outcomes in PBC
• The importance of bilirubin and alkaline phosphatase normalization

This episode is the first of 3 recap podcasts, featuring audio from our live satellite symposium, Raising the Bar: Innovations in PBC Care. For the full on-demand webcast of this satellite symposium, and to download the accompanying slides, visit the program page for this episode: https://bit.ly/44ZJ5os

Presenters:

Christopher L. Bowlus, MD
Lena Valente Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Aparna Goel, MD
Clinical Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Stanford University
Palo Alto, California

Aliya F. Gulamhusein, MD, MPH, FRCPC
Professorship in PSC Research
Clinician Investigator, Toronto General Hospital
Assistant Professor, University of Toronto
Division of Gastroenterology and Hepatology
University Health Network
Toronto, Canada

Get access to all of our new episodes by subscribing to the Decera Clinical Education Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join expert faculty, Dr Alan Bonder and Dr Stuart Gordon, to learn more about key gaps in PBC management and how these shortfalls can be addressed through identification of appropriate biochemical goals, proper assessment and management of PBC symptoms, and current second-line therapies.

Presenters:

Alan Bonder, MD, AGAF

Associate Professor of Medicine
Medical Director of Liver Transplant
Beth Israel Deaconess Medical Center
Department of Gastroenterology
Harvard Medical School
Boston, Massachusetts

Stuart C. Gordon, MD, FAASLD

Professor of Medicine
Wayne State University School of Medicine
Professor of Medicine
Michigan State University College of Medicine
Henry Ford Health
Detroit, Michigan

Link to full program:
https://bit.ly/3M29pI1

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Recent advances in primary biliary cholangitis (PBC) care have resulted in a new focus on personalized care and symptom management. Tune in to learn from patient advocate, Maria G. Morais, RN, how you can integrate patient insights and priorities into treatment plans for PBC. Topics covered include:

• The Canadian PBC Society Survey: Comorbidities and Treatment Goals
• Defining and Achieving Goal-Driven Care for PBC
• Recent Advances in PBC Management
• Newer Agents for Second-line Treatment of PBC

Presenters:

Maria G. Morais, RN
PBC Transplant Patient
VP Patient Advocacy
Canadian PBC Society
Toronto, Canada

Link to full program:
https://bit.ly/44ySoL3

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tune in to listen as expert faculty, Dr Christopher L. Bowlus and Dr Sonal Kumar, discuss recent developments in treating primary biliary cholangitis (PBC) with new and emerging agents, as well as strategies to integrate these advances into clinical practice.

Topics covered include:

• Methods of Assessing PBC Disease Progression
• Newer Agents for Second-line Treatment of PBC
• Prioritizing Symptom Management and Quality of Life With PBC Treatment

Presenters:

Christopher L. Bowlus, MD
Lena Valenta Professor and Chief
Division of Gastroenterology and Hepatology
School of Medicine
University of California Davis
Sacramento, California

Sonal Kumar, MD, MPH
Assistant Professor of Medicine
Division of Gastroenterology and Hepatology
Weill Cornell Medical College
New York, New York

Link to full program:
https://bit.ly/43nHx6U

Get access to all of our new podcasts by subscribing to the CCO Medical Specialties Podcast on Apple Podcasts, YouTube Music, or Spotify.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen as pulmonologist Peter Dicpinigaitis discusses his approach to the diagnosis and management of patients with refractory chronic cough in the context of a clinically relevant case and provides insights regarding emerging therapies.

Presenter
Peter Dicpinigaitis, MD
Professor of Medicine
Albert Einstein College of Medicine
Division of Critical Care Medicine
Montefiore Medical Center
Director, Montefiore Cough Center
Bronx, New York

Link to full program:
https://bit.ly/4kweynG

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen as Michael S. Benninger, MD, describes his approach to the diagnosis and management of chronic cough and refractory chronic cough in the context of a clinically relevant case.

Presenter
Michael S. Benninger, MD
Professor of Otolaryngology-Head and Neck Surgery
Lerner College of Medicine
The Cleveland Clinic
President, International Association of Phonosurgery
Cleveland, Ohio

Link to full program:
https://bit.ly/4kweynG

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Listen in as Joseph Kim, MD, MPH, MBA, and Colten Bracken, MD, FAAFP, discuss how to integrate comprehensive diabetes management to improve the quality of their obesity care delivery, including:

• Documenting obesity as a diagnosis for patients with diabetes when appropriate
• Streamlining processes to ensure patients return for follow-up
• Dedicating a care manager to initiate patient outreach
• Implementing pharmacotherapy strategies to help patients control their A1C and achieve weight loss simultaneously.

Presenters

Joseph Kim, MD, MPH, MBA
President
Q Synthesis, LLC
Newtown, Pennsylvania

Colten Bracken, MD, FAAFP
Board of Directors for RHAU & UAFP
Owner/Medical Director
Main Street Family Medicine, PLLC
Enterprise, Utah

Link to full program:
https://bit.ly/3IBFZi5

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH​, discusses the most recent developments in primary biliary cholangitis (PBC) treatment, including cutting-edge data on new and emerging agents and how these updates may be integrated into your practice. Topics include:

• Steatotic liver disease and PBC
• Vibration-controlled transient elastography (VCTE) and discordant biochemical responses in PBC
• PPAR agonists and IBATs for PBC treatment

Presenter:

Palak J. Trivedi, BSc, MBBS, PhD, MRCP, ESEGH
Associate Professor
NIHR Birmingham BRC
University of Birmingham
Consultant Hepatologist, Liver Unit
University Hospitals Birmingham
Birmingham, United Kingdom

Link to full program:
https://bit.ly/44ySoL3

Follow along with the slides:
https://bit.ly/3IvwQrj

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify

.

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Daniel C. Butler, MD, and Shawn G. Kwatra, MD, discuss the practical considerations for using IL-13 inhibitors to treat patients with moderate to severe atopic dermatitis, including:

• Patient candidacy considerations
• Treatment advancement strategies that go beyond topical therapies
• The importance of patient-centered care that address patients’ fears and needs
• A detailed patient case to highlight take home points

Presenter

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Shawn G. Kwatra, MD​
Dr. Joseph W. Burnett Endowed Professor and Chair ​
Department of Dermatology​
University of Maryland School of Medicine​
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Andrew F. Alexis, MD, MPH; Daniel C. Butler, MD; and Shawn G. Kwatra, MD, discuss IL-13 inhibition for treating patients with moderate to severe atopic dermatitis (AD), including:

• The available biologic therapies that specifically target IL-13
• Where these agents fall in the 2024 American Academy of Dermatology treatment algorithm
• How these agents compare to other AD therapies like topical corticosteroids and oral JAK inhibitors
• A detailed patient case to highlight take home points

Presenter

Andrew F. Alexis, MD, MPH​
Professor of Clinical Dermatology​
Weill Cornell Medical College ​
New York, New York

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Shawn G. Kwatra, MD​
Dr. Joseph W. Burnett Endowed Professor and Chair ​
Department of Dermatology​
University of Maryland School of Medicine​
Baltimore, Maryland

Program page:
https://bit.ly/4kTP04D

Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.